Process Design for Small-Scale Production of PEGDA-NVP Hydrogel Nanoparticle Emulsions for Therapeutic Applications
ACS Omega · 03.11.2026 · 11 (43) · 66317-66330
DOI: 10.1021/acsomega.6c04988 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Omega, online erschienen am 12.08.2026. Verfasst von Ruth Negru und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, Illinois Institute of Technology, Chicago, Illinois 60616, United States. Die Arbeit nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, Illinois Institute of Technology, National Institute of Allergy and Infectious Diseases.
Abstract (Originalsprache)
Hydrogel nanoparticle emulsions (HNEs) are promising platforms for intracellular therapeutic delivery, yet their synthesis at bench scale (267 mL) requires large quantities of material, which limits iterative optimization with high-value cargos. Here, we established a small-scale inverse phase (water-in-oil, W/O) miniemulsion polymerization (IPMP) process (15 mL) that reduced material requirements by >90% while maintaining key process design criteria. Using poly(ethylene glycol) diacrylate (PEGDA) and n-vinyl-2-pyrrolidinone (NVP), we demonstrate that the small-scale process maintains key measured formulation attributes, including nanoparticle tracking analysis (NTA)-derived particle diameter distributions, swelling ratios, swelling-derived mesh dimension estimations, and colloidal stability for at least three years. Process scale-down identified optimized parameters for homogenization, sonication, nitrogen purging, and reaction time and yielded nanoparticles with reproducible NTA-derived size metrics, concentration, and swelling-derived mesh dimension estimations. PEGDA-2000-based HNEs were cytocompatible according to International Organization for Standardization (ISO) 10993-5 exceeding the cytotoxic threshold (≥70% viability) under en masse administration. Fluorescently labeled HNE nanoparticles exhibited rapid internalization in adipocytes, which are typically resistant to transfection. With administration of HNEs loaded with green fluorescent protein (GFP) cargo, cells showed delayed appearance of GFP-associated fluorescence on day 8, consistent with time-dependent cargo release. Collectively, these findings establish a small-volume HNE synthesis platform that reduces material requirements while preserving evaluated formulation attributes across scales and demonstrating intracellular cargo delivery.
Autor:innen und Institutionen
- Department of Biomedical Engineering, Illinois Institute of Technology, Chicago, Illinois 60616, United States.
- Department of Chemical and Biological Engineering, Illinois Institute of Technology, Chicago, Illinois 60616, United States.
ORCID-Profile: Marcella K Vaicik
Förderung
- NIAID NIH HHS
- Illinois Institute of Technology
- National Institute of Allergy and Infectious Diseases
- Pritzker Institute of Biomedical Science and Engineering
Zitieren
APA
Negru, R., Borges, F. T. P., Papavasiliou, G., Teymour, F., & Vaicik, M. K. (2026). Process Design for Small-Scale Production of PEGDA-NVP Hydrogel Nanoparticle Emulsions for Therapeutic Applications. ACS Omega, 11(43), 66317-66330. https://doi.org/10.1021/acsomega.6c04988
Vancouver
Negru R, Borges FTP, Papavasiliou G, Teymour F, Vaicik MK. Process Design for Small-Scale Production of PEGDA-NVP Hydrogel Nanoparticle Emulsions for Therapeutic Applications. ACS Omega. 2026;11(43):66317-66330. doi:10.1021/acsomega.6c04988
BibTeX
@article{Negru2026,
author = {Negru, Ruth and Borges, Fernando T P and Papavasiliou, Georgia and Teymour, Fouad and Vaicik, Marcella K},
title = {Process Design for Small-Scale Production of PEGDA-NVP Hydrogel Nanoparticle Emulsions for Therapeutic Applications},
journal = {ACS Omega},
year = {2026},
volume = {11},
number = {43},
pages = {66317--66330},
doi = {10.1021/acsomega.6c04988}
}
EUVIMED